摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 2,8-dimethylimidazo[1,2-a]pyridine-3-carboxylate | 241146-66-7

中文名称
——
中文别名
——
英文名称
ethyl 2,8-dimethylimidazo[1,2-a]pyridine-3-carboxylate
英文别名
——
ethyl 2,8-dimethylimidazo[1,2-a]pyridine-3-carboxylate化学式
CAS
241146-66-7
化学式
C12H14N2O2
mdl
——
分子量
218.255
InChiKey
LALYREKEVNEKCM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    79-82°

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    43.6
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    使用 Rh(III) 催化对咪唑并[1,2-a]吡啶-3-甲酰胺进行定向区域选择性芳基化
    摘要:
    与之前报道的在 C-5 中心功能化咪唑并[1,2- a ]吡啶的自由基途径相比,指导基团方法很少见。在此,我们展示了一种铑( III )催化的高效和区域选择性策略,用于使用N-甲氧基酰胺作为定向基团对咪唑并[1,2- a ]吡啶进行定向C-5官能化。该方法有利于定向芳基化,无需预功能化。它还允许进行克级合成和后功能化。
    DOI:
    10.1039/d4ob01166j
  • 作为产物:
    描述:
    2-氨基-3-甲基吡啶2-氯乙酰乙酸乙酯乙醇 为溶剂, 反应 0.5h, 以41%的产率得到ethyl 2,8-dimethylimidazo[1,2-a]pyridine-3-carboxylate
    参考文献:
    名称:
    Microwave Assisted Synthesis of Disubstituted Imidazo[1,2-a]pyridine-3-carboxylic Acid Esters
    摘要:
    A novel and efficient synthetic method leveraging microwave-assisted organic synthesis (MAOS) to prepare disubstituted imidazo[1,2-a]pyridine-3-carboxylic acid esters (IPCEs) (3a-z), the key intermediates for a class of novel anti-tuberculosis agents, is reported. Under microwave heating at 120 degrees C for 20 or 30 min, the condensations of 2-aminopyridines (1a-k) and ethyl 2-halogenated acetoacetates (2a-d) were conveniently performed in ethanol with acceptable yields.
    DOI:
    10.3987/com-15-13299
点击查看最新优质反应信息

文献信息

  • Photocatalytic regeneration of brominating agent in the visible light-mediated synthesis of imidazo[1,2-<i>a</i>]pyridines
    作者:Irwan Iskandar Roslan、Kian-Hong Ng、Stephan Jaenicke、Gaik-Khuan Chuah
    DOI:10.1039/c9cy00141g
    日期:——
    supporting evidence of a reductive quenching pathway. The avoidance of stoichiometric excess of the halogen or peroxide oxidants for halide regeneration makes this protocol an environmentally-friendly synthesis with low E-factor.
    在可见光介导的光催化下,将1,3-二羰基与2-氨基吡啶偶联可以得到各种各样的咪唑并[1,2- a ]吡啶。使用便宜的和可商购的荧光素染料赤藓红B作为光氧化还原催化剂,KBr作为卤化剂进行原位溴化。该方案的特征在于使用催化量的卤化剂,该卤化剂由光催化剂在可见光照射下再生。循环伏安法研究提供了还原性淬灭途径的支持证据。避免化学计量过量的卤素或过氧化物氧化剂用于卤化物的再生,使该方案成为具有低E因子的环境友好的合成方法。
  • Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents
    作者:Apeng Wang、Kai Lv、Linhu Li、Hongtao Liu、Zeyu Tao、Bin Wang、Mingliang Liu、Chao Ma、Xican Ma、Bing Han、Aoyu Wang、Yu Lu
    DOI:10.1016/j.ejmech.2019.06.038
    日期:2019.9
    A series of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides (IPAs), based on the structure of WZY02 discovered in our lab, were designed and synthesized as new anti-TB agents. Results reveal that many of them exhibit excellent in vitro inhibitory activity with low nanomolar MIC values against both drug-sensitive MTB strain H37Rv and drug-resistant clinical isolates. Compounds 15b and 15d display
    根据在我们实验室中发现的WZY02的结构,设计并合成了一系列N-(2-苯氧基)乙基咪唑并[1,2 - a ]吡啶-3-甲酰胺(IPAs),作为新型抗结核药物。结果表明,它们中的许多对药物敏感性MTB菌株H37Rv和耐药性临床分离株均表现出优异的体外抑制活性,且纳摩尔摩尔MIC值低。化合物15b和15d显示出良好的安全性和药代动力学特征,表明它们有望成为未来抗结核药物发现的先导化合物。
  • Advancement of Imidazo[1,2-<i>a</i>]pyridines with Improved Pharmacokinetics and nM Activity vs. <i>Mycobacterium tuberculosis</i>
    作者:Garrett C. Moraski、Lowell D. Markley、Jeffrey Cramer、Philip A. Hipskind、Helena Boshoff、Mai A. Bailey、Torey Alling、Juliane Ollinger、Tanya Parish、Marvin J. Miller
    DOI:10.1021/ml400088y
    日期:2013.7.11
    A set of 14 imidazo[1,2-a]pyridine-3-carboxamides was synthesized and screened against Mycobacterium tuberculosis H(37)Rv. The minimum inhibitory concentrations of 12 of these agents were <= 1 mu M against replicating bacteria and 5 compounds (9, 12, 16, 17, and 18) had MIC values <= 0.006 mu M. Compounds 13 and 18 were screened against a panel of MDR and XDR drug resistant clinical Mtb strains with the potency of 18 surpassing that of clinical candidate PA-824 by nearly 10-fold. The in vivo pharmacokinetics of compounds 13 and 18 were evaluated in male mice by oral (PO) and intravenous (IV) routes. These results indicate that readily synthesized imidazo[1,2-a]pyridine-3-carboxamides are an exciting new class of potent, selective anti-TB agents that merit additional development opportunities.
  • Microwave Assisted Synthesis of Disubstituted Imidazo[1,2-a]pyridine-3-carboxylic Acid Esters
    作者:Ming-liang Liu、Qiu-rong Zhang、Lin-hu Li、Zhao-yang Wu、Zhuo-rong Li、Hui-yuan Guo
    DOI:10.3987/com-15-13299
    日期:——
    A novel and efficient synthetic method leveraging microwave-assisted organic synthesis (MAOS) to prepare disubstituted imidazo[1,2-a]pyridine-3-carboxylic acid esters (IPCEs) (3a-z), the key intermediates for a class of novel anti-tuberculosis agents, is reported. Under microwave heating at 120 degrees C for 20 or 30 min, the condensations of 2-aminopyridines (1a-k) and ethyl 2-halogenated acetoacetates (2a-d) were conveniently performed in ethanol with acceptable yields.
  • 10.1039/d4ob01166j
    作者:Jahan, Kousar、Sood, Mehak、Jain, Osheen、Sahoo, Subash C.、Bharatam, Prasad V.
    DOI:10.1039/d4ob01166j
    日期:——
    In contrast to previously reported free-radical pathways to functionalize imidazo[1,2-a]pyridines at the C-5 centre, directing group approaches are rare. Herein, we demonstrate a rhodium(III) catalyzed efficient and regioselective strategy for directed C-5 functionalization of imidazo[1,2-a]pyridines using N-methoxyamide as a directing group. This methodology facilitates directed arylation without
    与之前报道的在 C-5 中心功能化咪唑并[1,2- a ]吡啶的自由基途径相比,指导基团方法很少见。在此,我们展示了一种铑( III )催化的高效和区域选择性策略,用于使用N-甲氧基酰胺作为定向基团对咪唑并[1,2- a ]吡啶进行定向C-5官能化。该方法有利于定向芳基化,无需预功能化。它还允许进行克级合成和后功能化。
查看更多

同类化合物

阿法拉定A,TFA 钠(E)-2-氰基-3-[2,8-二(丙-2-基氧基)咪唑并[3,2-a]吡啶-3-基]丙-2-烯酸酯 诺白拉斯啶 苯酚,4-(5,6,7,8-四氢咪唑并[1,2-a]吡啶-8-基)- 米诺膦酸 米诺磷酸一水合物 硫酸利美戈潘 盐酸法屈唑半水合物 盐酸依格列汀 甲基咪唑并[1,5-A]吡啶-1-甲酸叔丁酯 甲基3-氨基咪唑并[1,2-a]吡啶-5-羧酸酯 甲基-(7-甲基咪唑并[1,2-A〕吡啶-2-基甲基)-胺 甲基-(5-甲基-咪唑并[1,2-A]吡啶-2-甲基)-胺 甲基 2-甲基咪唑并[1,2-a]吡啶-3-羧酸 环戊烷羧酸2-氨基-4-亚甲基-,(1R,2S)-(9CI) 环巴胺抑制剂1 泰妥拉唑 法倔唑盐酸盐 法倔唑 沃利替尼(对映异构体) 沃利替尼 氨基膦酸杂质14 巴马鲁唑 奥克塞米索 地扎胍宁甲磺酸盐 地扎胍宁 土大黄甙 咪唑磺隆 咪唑并吡啶-2-酮盐酸盐 咪唑并吡啶-2-酮 咪唑并二甲基吡啶 咪唑并[2,1-a]异喹啉-2(3H)-酮 咪唑并[1,5-a]吡啶-8-胺 咪唑并[1,5-a]吡啶-8-羧酸乙酯 咪唑并[1,5-a]吡啶-8-甲醛 咪唑并[1,5-a]吡啶-7-羧酸甲酯 咪唑并[1,5-a]吡啶-7-羧酸乙酯 咪唑并[1,5-a]吡啶-6-羧酸甲酯 咪唑并[1,5-a]吡啶-6-羧酸乙酯 咪唑并[1,5-a]吡啶-5-胺 咪唑并[1,5-a]吡啶-5-羧酸甲酯 咪唑并[1,5-a]吡啶-5-羧酸乙酯 咪唑并[1,5-a]吡啶-5-甲醛 咪唑并[1,5-a]吡啶-3-羧酸乙酯 咪唑并[1,5-a]吡啶-3-磺酰胺 咪唑并[1,5-a]吡啶-3-甲醛 咪唑并[1,5-a]吡啶-3(2H)-硫酮 咪唑并[1,5-a]吡啶-1-羧醛 咪唑并[1,5-a]吡啶-1-磺酰胺 咪唑并[1,5-a]吡啶-1-基-甲醇